Ogdie, Alexis
Merola, Joseph F.
Mease, Philip J.
Ritchlin, Christopher T.
Scher, Jose U.
Lafferty, Kimberly Parnell
Chan, Daphne
Chakravarty, Soumya D.
Langholff, Wayne
Wang, Yanli
Choi, Olivia
Krol, Yevgeniy
Gottlieb, Alice B.
Funding for this research was provided by:
Janssen Research and Development
Article History
Received: 14 August 2023
Accepted: 12 April 2024
First Online: 21 May 2024
Declarations
:
: The study is being conducted in compliance with the Declaration of Helsinki and International Council for Harmonization Guidelines for Good Clinical Practice. The study was approved by Sterling Institutional Review Board for most sites in the United States (full list available in the ). Prior to participation in any study-related procedures, patients will provide written informed consent; additional consent will be collected for optional pharmacogenomic analyses.
: Not applicable.
: AO has received grant/research support to the University of Pennsylvania from AbbVie, Janssen, Novartis, and Pfizer and to Forward from Amgen; consultant fees from AbbVie, Amgen, Bristol Myers Squibb, Celgene, CorEvitas, Eli Lilly, Gilead, Happify Health, Janssen, Novartis, Pfizer, and UCB; Dr. Ogdie’s husband has received royalties from Novartis.JFM has received consulting fees and investigator honoraria from AbbVie, Amgen, Biogen, Bristol Myers Squibb, Dermavant, Eli Lilly, Incyte, Janssen, Leo Pharma, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma, and UCB. JFM was affiliated with Brigham and Women’s Hospital, Harvard Medical School when this worked was performed; current affiliation is now Department of Dermatology, and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center, Dallas, TX, USA.PJM has received research grants from AbbVie, Acelyrin, Amgen, Bristol Myers Squibb, Eli Lilly, Janssen, Novartis, Pfizer, SUN, and UCB; consulting fees from AbbVie, Acelyrin, Aclaris, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Galapagos, Gilead, GlaxoSmithKline, Immagene, Janssen, Novartis, Pfizer, SUN, UCB, Ventyx; speaker fees from AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer, and UCB.CTR has received grant/research support from AbbVie, Amgen, and UCB; and consulting fees from Amgen, AbbVie, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, and UCB.JUS has received consulting fees for AbbVie, Janssen, Novartis, Pfizer, Sanofi, Kaleido and UCB; and funding for investigator-initiated studies from Novartis, Pfizer and Janssen.ABG has received honoraria as an advisory board member and consultant for Amgen, AnaptypsBio, Avotres Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Dice Therapeutics, Eli Lilly, Janssen, Novartis, Sanofi, Teva, UCB, and Xbiotech and has received research/educational grants from Bristol Myers Squibb, Highlights Therapeutics, Janssen, and UCB (all paid to Mount Sinai School of Medicine).KPL, DC, SDC, OC, and YK are employees of Janssen Scientific Affairs, LLC and own stock in Johnson & Johnson. WL is an employee of Janssen Research & Development, LLC and owns stock in Johnson & Johnson. YW is employee of IQVIA providing statistical support (funded by Janssen).